|
WO2021063972A1
|
|
Cthrc1 as biomarker for a tgfbeta-activated tumor microenvironment
|
|
WO2020120576A1
|
|
p38α AUTOPHOSPHORYLATION INHIBITORS
|
|
WO2020104648A2
|
|
TGFβ INHIBITOR AND PRODRUGS
|
|
EP3798633A1
|
|
Predictive biomarkers for treatment of a cancer patient with tgf-beta signaling pathway inhibitors
|
|
WO2019086437A1
|
|
A compound comprising rna compounds and bcm moieties
|
|
EP3415164A1
|
|
Composition comprising a specific p38a inhibitor and an agent that induces chromosome instability and medical uses thereof
|
|
EP3650468A1
|
|
Targeting metastasis stem cells through a fatty acid receptor (cd36)
|
|
WO2015150921A2
|
|
Methods for treating prostate cancer
|
|
CA2926894A1
|
|
Method for the prognosis and treatment of metastasizing cancer of the bone originating from breast cancer
|
|
CA2906394A1
|
|
Method for the prognosis and treatment of cancer metastasis
|
|
AU2014229563A1
|
|
Method for the diagnosis, prognosis and treatment of cancer metastasis
|
|
EP3467124A1
|
|
Method for the diagnosis, prognosis and treatment of lung cancer metastasis
|
|
KR20190009835A
|
|
Method for the diagnosis, prognosis and treatment of breast cancer metastasis
|
